← Back to Hypothesis | Reviews

⭐ Pre-Symptomatic Dawn-Administration for Phase-Advance Targeting

Composite Score: 0.335 | Target: MT2 receptor (Gq/11 coupling); PER1/2; SCN pacemaking neurons

Filter by type:

No structured reviews yet. Be the first to review this hypothesis!